肾功能对接受多次钆布醇给药患者中枢神经系统钆沉积的影响
本回顾性研究纳入2014年2月1日至2018年1月1日间接受≥10次脑MR增强并静脉注射钆布醇的131例患者(73例女性,末次扫描平均年龄55.9岁),计算齿状核/脑桥及苍白球/丘脑信号强度比值从首次至末次扫描的百分比变化,并与估算肾小球滤过率(最小值和平均值)行相关分析。结果显示肾功能与上述信号强度比值变化无显著相关性,即使轻中度肾功能不全者亦然。
要点
- 接受平均12次静脉钆布醇给药的患者,齿状核/脑桥信号强度比值平均变化0.31%,苍白球/丘脑平均变化0.15%。
- 最小估算肾小球滤过率与齿状核/脑桥信号变化无显著相关(r=-0.09,P=.28),平均估算肾小球滤过率亦无显著相关(r=-0.09,P=.30)。
- 控制年龄、性别、扫描次数和总剂量后,肾功能与齿状核/脑桥及苍白球/丘脑信号变化仍无显著相关。
关键影像表现/征象
- 齿状核/脑桥信号强度比值从首次至末次扫描的平均百分比变化为0.31%。
- 苍白球/丘脑信号强度比值从首次至末次扫描的平均百分比变化为0.15%。
诊断标准与关键数值
- 未发现最小估算肾小球滤过率与齿状核/脑桥信号强度比值百分比变化显著相关(r=-0.09,P=.28)。
- 未发现平均估算肾小球滤过率与齿状核/脑桥信号强度比值百分比变化显著相关(r=-0.09,P=.30)。
- 未发现最小估算肾小球滤过率与苍白球/丘脑信号强度比值百分比变化显著相关(r=0.07,P=.43)。
- 未发现平均估算肾小球滤过率与苍白球/丘脑信号强度比值百分比变化显著相关(r=0.07,P=.40)。
- 控制年龄、性别、扫描次数和总剂量后,最小估算肾小球滤过率与齿状核/脑桥信号变化无显著相关(r=0.16,P=.07),平均估算肾小球滤过率亦无显著相关(r=0.15,P=.08);最小估算肾小球滤过率与苍白球/丘脑信号变化无显著相关(r=-0.14,P=.12),平均估算肾小球滤过率亦无显著相关(r=-0.15,P=.09)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Studies associate repeat gadolinium-based contrast agent administration with T1 shortening in the dentate nucleus and globus pallidus, indicating CNS gadolinium deposition, most strongly with linear agents but also reportedly with macrocyclics. Renal impairment effects on long-term CNS gadolinium deposition remain underexplored. We investigated the relationship between signal intensity changes and renal function in patients who received ≥10 administrations of the macrocyclic agent gadobutrol.
MATERIALS AND METHODS: Patients who underwent ≥10 brain MR imaging examinations with administration of intravenous gadobutrol between February 1, 2014, and January 1, 2018, were included in this retrospective study. Dentate nucleus-to-pons and globus pallidus-to-thalamus signal intensity ratios were calculated, and correlations were calculated between the estimated glomerular filtration rate (minimum and mean) and the percentage change in signal intensity ratios from the first to last scan. Partial correlations were calculated to control for potential confounders.
RESULTS: One hundred thirty-one patients (73 women; mean age at last scan, 55.9 years) showed a mean percentage change of the dentate nucleus-to-pons of 0.31%, a mean percentage change of the globus pallidus-to-thalamus of 0.15%, a mean minimum estimated glomerular filtration rate of 69.65 (range, 10.16-132.26), and a mean average estimated glomerular filtration rate at 89.48 (range, 38.24-145.93). No significant association was found between the estimated glomerular filtration rate and percentage change of the dentate nucleus-to-pons (minimum estimated glomerular filtration rate, r = -0.09, P = .28; average estimated glomerular filtration rate, r = -0.09, P = .30,) or percentage change of the globus pallidus-to-thalamus (r = 0.07, P = .43; r = 0.07, P = .40). When we controlled for age, sex, number of scans, and total dose, there were no significant associations between the estimated glomerular filtration rate and the percentage change of the dentate nucleus-to-pons (r = 0.16, P = .07; r = 0.15, P = .08) or percentage change of the globus pallidus-to-thalamus (r = -0.14, P = .12; r = -0.15, P = .09).
CONCLUSIONS: In patients receiving an average of 12 intravenous gadobutrol administrations, no correlation was found between renal function and signal intensity ratio changes, even in those with mild or moderate renal impairment.
引用
- Dogra S, Borja MJ, Lui YW, et al. Impact of Kidney Function on CNS Gadolinium Deposition in Patients Receiving Repeated Doses of Gadobutrol. AJNR Am J Neuroradiol. 2021. PMID: 33632738. doi:10.3174/ajnr.A7031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。